Alyeska Investment Group, L.P. - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 40 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$897,537
+34.5%
202,1480.0%0.01%
+20.0%
Q2 2023$667,088
+53.8%
202,148
+32.9%
0.01%
+25.0%
Q1 2023$433,622
-91.8%
152,148
-66.4%
0.00%
-94.7%
Q4 2020$5,302,000
+220.4%
452,797
+116.9%
0.08%
+200.0%
Q3 2020$1,655,000
+31.7%
208,757
+176.3%
0.02%
+47.1%
Q4 2019$1,257,000
+26.0%
75,551
-49.7%
0.02%
+21.4%
Q3 2019$998,000150,2650.01%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
TRV GP IV, LLC 2,343,154$10,403,6043.92%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,718,881$25,391,8321.37%
COWEN AND COMPANY, LLC 4,308,359$19,129,1131.34%
RA Capital Management 11,609,704$51,547,0861.02%
RTW INVESTMENTS, LP 5,818,804$25,835,4900.54%
Acuitas Investments, LLC 134,811$598,5610.35%
Simplify Asset Management Inc. 570,519$2,533,1040.29%
Vivo Capital, LLC 520,000$2,308,8000.25%
BRANDYWINE MANAGERS, LLC 26,127$116,0040.20%
DENALI ADVISORS LLC 70,600$313,4640.11%
View complete list of FULCRUM THERAPEUTICS INC shareholders